Two Sigma Securities’s Ginkgo Bioworks DNA Stock Holding History

Two Sigma Securities’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,853	Closed	-$51.5K	–	3033
2024 Q2	$51.5K	Buy	3,853 +301	+8%	+$8.98K	﹤0.01%	2570
2024 Q1	$165K	Buy	+3,552	New	+$184K	﹤0.01%	2386
2023 Q3	–	Sell	-1,002	Closed	-$74.5K	–	3042
2023 Q2	$74.5K	Sell	1,002 -1,551	-61%	-$91.8K	﹤0.01%	2346
2023 Q1	$136K	Buy	2,553 +191	+8%	+$12.1K	﹤0.01%	2158
2022 Q4	$160K	Buy	2,362 +2,066	+698%	+$190K	﹤0.01%	1996
2022 Q3	$37K	Buy	+296	New	+$35.3K	﹤0.01%	2221

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Securities's DNA Position: Q3 2024 in Review

Two Sigma Securities sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 3,853 shares — an estimated $51.5K sold.

Two Sigma Securities first reported a position in DNA in Q3 2022 and held it in 6 quarters. The position peaked at $165K in Q1 2024. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

Two Sigma Securities reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 3,853 Ginkgo Bioworks shares in Q3 2024, an estimated $51.5K.
Two Sigma Securities first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 6 quarters.
Two Sigma Securities's Ginkgo Bioworks position peaked at $165K in Q1 2024.
159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.